OvaScience: OvaScience, VC Fund Settle Investor Class Action For $15M
OvaScience and its venture capital backer Longwood Fund have agreed to pay $15 million to resolve an investor class action saying the Massachusetts fertility company's alleged misrepresentations about the success of a new treatment eventually led to shareholder losses.
Read full article »
CEO
OvaScience is a biopharmaceutical company that discovers, develops and commercializes infertility treatment methods for women and couples.
Read more